S01 E03
Surgibots Podcast

Surgical Robotics of the Future

Surgical robotics are providing innovative healthcare for the future, but what does the future look like for the industry?

Surgical Robotics of the Future

ALSO AVAILABLE ON

SpotifyApple podcastsAmazon music
Share
Surgibots Ep 3

Surgical Robotics of the Future

Surgical robotics are providing innovative healthcare for the future, but what does the future look like for the industry? On The Surgibots Podcast we spoke to Michael Schmid-Santek, the CEO of BHS Technologies. With a background in mechanical engineering, he’s worked in medical devices for around 17 years, with a specialism in heart catheters. We talked about the developments that BHS Technologies have made to advance the surgical robotics industry, as well as his predictions for the sector as a whole.  

You’ve created collaborative plug-ins, how is that going to affect the market?  

MMI has adopted our technology, or as they call it ‘also included our device’, for their solutions. We’re able to demonstrate how their system could be used with ours. We are also part of their solutions, which makes us pretty proud. It's also the other way around - we do have distributors and doctors who are asking about installations because they also want to see that setup. Other companies probably don't want to lock into one microscope vendor, because it doesn't make any sense for them. If a surgeon has already bought a brand new extra scope and doesn't need the robotics club anymore, then he should not have to buy robotics. It’s all about the options we can provide.  

How do you see funding happening in the future? 

The ideal case for our company would be that we will get revenue through what we are making and selling. We know that we have to speed up here and there, especially when we need a second series. That's the plan for now, just to raise another round of growth capital, then stay ahead of the others. We're playing with similar technologies. We're getting to a point where - fingers crossed - our revenue supports our growth. 

What do you see as the challenges that you're going to have to overcome in the next couple of years? 

Implementing disruptive technology is always going to be a challenge. So is finding a new company and developing something innovative. We are still in the niche, and need to expand that niche day by day. Fundraising will be a challenge with the current situation in the economy. The Ukraine / Russia war is challenging too, but we don't worry about supply chains, because that's something we set up very well. So yeah, there are challenges, but we’re not worried about getting through them.  

What do you see as future trends in the surgical robotics industry?  

We’re seeing lots of projects that focus on invasive systems. That's one general trend that you can ignore. On the other hand, what I think is super exciting, is the intuitive system. I think that having more specific robots for specific procedures is going to be the future of the industry. That's a more interesting trend in my opinion. We’re seeing devices in laparoscopic surgical robots for example, that insert a Cochlear electrode, and improve patients’ residual hearing and stuff like that. Interventional Systems are also building one tiny robot for interventional surgical procedures and biopsies, which allows us to analyse the data it collects too. AI will keep getting stronger to support doctors and surgical robots too. 

What advice would you give to people who come into the industry in the future? 

Don't just do it. Know the use cases for what you’re doing. Don't be afraid of going down that path and plan for not just one extra mile, plan for lots more extra extra miles. It's getting more and more competitive in the field, so be prepared for that. If you want to move in a specific direction, you have to know the weaknesses of the other devices in that niche to build something remarkable. That's true for every product you develop. When you decide to develop one super specific robot for one super specific procedure, then you've got to involve as many surgeons as soon as possible to evaluate if the idea really makes sense, and if it has a large enough audience. Who's willing to pay the bills for it? The industry is a lot of fun, but a lot of pain too.  

What do you think are the three top technologies that we're going to see in the surgical robotics sector in the future? 

What's going to support various robots and functionalities is AI. That's going to support part of or the whole device within augmented reality. Having augmented reality allows you to get more information to the microsurgical cockpit, so that the surgeon has all the information needed - maybe a bit more. Connected devices are also something with potential. In the future we could see a standard interface that you're able to connect various devices to. The devices will be able to collaborate more if they are connected and communicating with each other, controlling functions, and stuff like that. There’s so much potential.  

To learn more about where the surgical robotics industry is heading, tune into The Surgibots Podcast here.  

 

LISTEN ON YOUR FAVOURITE PODCAST PLATFORM
SpotifyApple podcastsAmazon music

More episodes in this industry

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental
Podcast41

Clinically Beautiful Smiles, Made with Robots - Paul Roberts, CEO of Lupin Dental

Join host Henry Norton in this episode of The Crux of Medtech as he speaks to Paul Roberts, co-founder of CMR Surgical and current CEO of Lupin Dental. Paul shares the journey from building surgical robots in a former pig shed to co-founding one of the most recognised names in robotic surgery. Now, he’s applying that experience to an entirely new frontier, aesthetic dental robotics. In this episode, Paul explains why dental veneers are about more than vanity, how robotic precision can eliminate outdated practices like tooth stumping, and why Lupin’s tech could completely transform smile restoration. He also opens up about his medtech philosophy, including why engineers shouldn’t build products alone, and what it really takes to move from zero to launch in a capital-intensive field like robotics. Key Topics Why Paul left surgical robotics for dental robotics The founding story of CMR Surgical The clinical and aesthetic importance of veneers How Lupin reduces a 5-visit dental process into 1 What medtech can learn from AlignTech and Invisalign Building a profitable robot company without hundreds of millions Related Insights Crowns are outdated. Robotic veneers restore enamel with less damage Engineers alone don’t make great products clinicians must co-create One robotic session at Lupin replaces five traditional dental visits India is a strategic first market and a smart regulatory play Fail fast, but never compromise on patient safety Core Challenges Tooth restoration has long been inefficient: dentists rely on hand-guesswork for shaping and prepping teeth. It’s a manual, error-prone process that requires multiple appointments and can cause long-term sensitivity. Lupin Dental solves this with AI-powered planning, CAD design, and a precision robot that prepares the tooth and bonds the veneer all in one session. Tune in now to hear how surgical-grade robotics are reshaping the smile economy and why Lupin Dental could be the next CMR.
Artificial Intelligence Feels Like Magic - With Peter Verrillo
Podcast40

Artificial Intelligence Feels Like Magic - With Peter Verrillo

Meet Peter Verrillo, the CEO of Redefine Surgery. He joins your host, Henry Norton, in this episode to discuss the latest developments in orthopaedic AI. Throughout the conversation, Peter highlights how time-consuming knee surgery can be, and talks about the AI solutions that his company is creating to reduce the time spent in theatre. Peter also shares his journey as a founder of multiple different companies, touching on everything from funding and acquisitions to building prototypes in his basement. He also emphasises the benefits of working with device-manufacturing companies, as they will take his AI to market under a whitelabel. He states that this relationship is a key part of the medtech industry. Peter also touches on the importance of strong sales reps, suggesting that they should have training in both the software and robotics sides of this new technology in order to efficiently translate it to surgeons.

Discover more about Medical Devices